Effect of MER-29 on Egg Production in the Chicken

T. L. Burgess, C. L. Burgess, J. D. Wilson

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Administration of MER-29 to laying hens is followed over a 2-week period by gradual replacement of 85% of the egg cholesterol by desmosterol. The accumulation of desmosterol in the egg is followed by cessation of egg production; following withdrawal of MER-29 from the diet, egg production returns to normal only after a lag phase of 12 days. This sequence of events suggests that MER-29 inhibits maturation of the ova rather than the subsequent events in egg formation.

Original languageEnglish (US)
Pages (from-to)218-221
Number of pages4
JournalProceedings of the Society for Experimental Biology and Medicine
Volume109
Issue number1
DOIs
StatePublished - 1962

Fingerprint

Triparanol
Desmosterol
Ovum
Chickens
Nutrition
Cholesterol
Diet

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Effect of MER-29 on Egg Production in the Chicken. / Burgess, T. L.; Burgess, C. L.; Wilson, J. D.

In: Proceedings of the Society for Experimental Biology and Medicine, Vol. 109, No. 1, 1962, p. 218-221.

Research output: Contribution to journalArticle

Burgess, T. L. ; Burgess, C. L. ; Wilson, J. D. / Effect of MER-29 on Egg Production in the Chicken. In: Proceedings of the Society for Experimental Biology and Medicine. 1962 ; Vol. 109, No. 1. pp. 218-221.
@article{fc8e6c69bdd64002a7558d79dda69c1e,
title = "Effect of MER-29 on Egg Production in the Chicken",
abstract = "Administration of MER-29 to laying hens is followed over a 2-week period by gradual replacement of 85{\%} of the egg cholesterol by desmosterol. The accumulation of desmosterol in the egg is followed by cessation of egg production; following withdrawal of MER-29 from the diet, egg production returns to normal only after a lag phase of 12 days. This sequence of events suggests that MER-29 inhibits maturation of the ova rather than the subsequent events in egg formation.",
author = "Burgess, {T. L.} and Burgess, {C. L.} and Wilson, {J. D.}",
year = "1962",
doi = "10.3181/00379727-109-27158",
language = "English (US)",
volume = "109",
pages = "218--221",
journal = "Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)",
issn = "1535-3702",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Effect of MER-29 on Egg Production in the Chicken

AU - Burgess, T. L.

AU - Burgess, C. L.

AU - Wilson, J. D.

PY - 1962

Y1 - 1962

N2 - Administration of MER-29 to laying hens is followed over a 2-week period by gradual replacement of 85% of the egg cholesterol by desmosterol. The accumulation of desmosterol in the egg is followed by cessation of egg production; following withdrawal of MER-29 from the diet, egg production returns to normal only after a lag phase of 12 days. This sequence of events suggests that MER-29 inhibits maturation of the ova rather than the subsequent events in egg formation.

AB - Administration of MER-29 to laying hens is followed over a 2-week period by gradual replacement of 85% of the egg cholesterol by desmosterol. The accumulation of desmosterol in the egg is followed by cessation of egg production; following withdrawal of MER-29 from the diet, egg production returns to normal only after a lag phase of 12 days. This sequence of events suggests that MER-29 inhibits maturation of the ova rather than the subsequent events in egg formation.

UR - http://www.scopus.com/inward/record.url?scp=34249882536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249882536&partnerID=8YFLogxK

U2 - 10.3181/00379727-109-27158

DO - 10.3181/00379727-109-27158

M3 - Article

C2 - 13874831

AN - SCOPUS:34249882536

VL - 109

SP - 218

EP - 221

JO - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

JF - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

SN - 1535-3702

IS - 1

ER -